{"id":"NCT00511797","sponsor":"Bayer","briefTitle":"SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study","officialTitle":"A Multicenter, Double-blind, Randomized, Placebo-controlled Comparative Study to Investigate the Optimal Dose of Drospirenone for Dysmenorrhea With SH T04740A [Drospirenone 1 mg/Ethinylestradiol 20 µg (as ß-cyclodextrin Clathrate)], SH T 04740E [Drospirenone 2 mg/Ethinylestradiol 20 µg (as ß-cyclodextrin Clathrate)] and SH T00186D [Drospirenone 3 mg/ Ethinylestradiol 20 µg (as ß-cyclodextrin Clathrate)] Administered Orally for 16 Weeks (4 Cycles), and to Confirm the Efficacy of SH T00186D for Dysmenorrhea.","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2007-07","primaryCompletion":"2009-01","completion":"2009-01","firstPosted":"2007-08-06","resultsPosted":"2010-10-04","lastUpdate":"2017-01-26"},"enrollment":249,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Dysmenorrhea"],"interventions":[{"type":"DRUG","name":"SH T04740B","otherNames":[]},{"type":"DRUG","name":"SH T00186DF","otherNames":[]},{"type":"DRUG","name":"SH T04740F","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"DRSP 1 mg/EE 20 μg","type":"EXPERIMENTAL"},{"label":"DRSP 2 mg/EE 20 μg","type":"EXPERIMENTAL"},{"label":"DRSP 3 mg/EE 20 μg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to investigate efficacy of drospirenone for dysmenorrhea.","primaryOutcome":{"measure":"Change From Baseline in Total Dysmenorrheal Score at Final Evaluation","timeFrame":"Baseline and up to 4 Cycles (28 days per cycle)","effectByArm":[{"arm":"DRSP 1 mg/EE 20 μg","deltaMin":-2.5,"sd":1.52},{"arm":"DRSP 2 mg/EE 20 μg","deltaMin":-2.1,"sd":1.51},{"arm":"DRSP 3 mg/EE 20 μg","deltaMin":-1.9,"sd":1.63},{"arm":"Placebo","deltaMin":-1,"sd":1.53}],"pValues":[{"comp":"OG002 vs OG003","p":"<0.001"},{"comp":"OG001 vs OG003","p":"<0.001"},{"comp":"OG000 vs OG003","p":"<0.001"}]},"eligibility":{"minAge":"20 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":10},"locations":{"siteCount":12,"countries":["Japan"]},"refs":{"pmids":["37523477"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":62},"commonTop":["Headache","Nasopharyngitis","Dysmenorrhoea","Nausea","Genital haemorrhage"]}}